CTXR — Citius Pharmaceuticals, Inc.

CTXRCitius Pharmaceuticals, Inc.

NAS · US · Healthcare · Biotechnology · citiuspharma.com

0.6980USD-0.43%Mkt Cap: 18.96M USDP/E: —Last update: 2026-05-26

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment o…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap18.96M USD

Enterprise Value22.24M USD

Revenue (TTM)5.61M USD

Gross Profit4.49M USD

Net Income (TTM)-37.43M USD

Revenue/Share0.3110 USD

Last Price0.6980 USD

Fiscal Year EndSep 2025

MR QuarterMar 2026

Employees23

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)0.68

PEG—

EV/EBITDA-0.41

EV/Revenue3.96

P/S3.29

P/B0.19

EPS (TTM)-2.14

EPS (Forward)0.99

52W Range

0.476011% of range2.480

52W High2.480 USD

52W Low0.4760 USD

Profitability

Gross Margin80.07%

Oper. Margin-1827.78%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-55.42%

ROA-28.59%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-26.55M USD

CapEx (TTM)—

FCF Margin-599.41%

FCF Yield-177.44%

Net Debt-3.78M USD

Net Debt/EBITDA0.07

Balance Sheet

Debt/Equity0.03

Current Ratio0.58

Quick Ratio0.10

Book Value/Sh3.573 USD

Cash/Share0.1670 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateJun 9, 2017

Splits

Last Split1:25

Split DateNov 26, 2024

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)5.000 USD

Target Range4.000 USD – 6.000 USD

# Analysts2

Ownership

Shares Out.27.45M

Float26.95M

Insiders1.80%

Institutions3.63%

Short Interest

Short Ratio6.3d

Short % Float19.52%

Short % Out.19.17%

Shares Short5.26M

Short (prev mo.)3.91M

Technical

SMA 500.7553 (-7.6%)

SMA 2001.022 (-31.7%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)966.58K

Avg Vol (10d)1.05M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—